Digital PCR (dPCR) is an excellent tool for rare target analysis applications because, unlike traditional PCR methods, dPCR divides samples into thousands of individual microreactions, then amplifies isolated molecules to endpoint. This helps to isolate even very small amounts of target for improved chances of detection and quantification. For applications such as CAR-T cell therapy research, where the frequencies of targets are often very low, dPCR is an extremely advantageous tool.
Dr. Raquel Munoz Garcia is an immunologist from the Hospital Universitario Virgen del Rocío in Seville, Spain. In this webinar, she discusses how dPCR was used to support CAR-T cell monitoring research.
Interested in hearing more? Listen to the episode of our Absolute Gene-ius podcast when we had the opportunity to talk with Dr. Munoz and learn more about what she thinks will be the future of cancer research.
For Research Use Only. Not for use in diagnostic procedures.